Annalisa Jenkins

Annalisa Jenkins is an experienced pharmaceutical executive having held positions as the President and Chief Executive Officer at leading gene therapy company Dimension Therapeutics, head of global R&D at EMD Serono, and roles at BMS. Dr.Jenkins is a member of the board of directors of multiple companies including Ardelyx, Inc., iOX Therapeutics Limited, MedCity, TSI, Cocoon Biotech Inc, and Vium (elected to Executive Chair in 2017). She also is a committee member of the Science Board to the U.S. Food & Drug Administration, and serves on the board of the Center for Talent Innovation (U.K.). She is also an executive committee member of Springboard Enterprises, and is on the Advisory Panel of the Healthcare Businesswomen’s Association.